-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q4 2024.
- Taysha Gene Therapies, Inc. Depreciation for the quarter ending December 31, 2024 was $320K, a 5.88% decline year-over-year.
- Taysha Gene Therapies, Inc. Depreciation for the twelve months ending December 31, 2024 was $1.25M, a 9.19% decline year-over-year.
- Taysha Gene Therapies, Inc. annual Depreciation for 2024 was $1.25M, a 9.19% decline from 2023.
- Taysha Gene Therapies, Inc. annual Depreciation for 2023 was $1.37M, a 17% increase from 2022.
- Taysha Gene Therapies, Inc. annual Depreciation for 2022 was $1.17M, a 138% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)